Recent News View All News

U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

April 29, 2025

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 1, 2025

View All News

Upcoming Events View IR Calendar

Annual Meeting of Stockholders

May 19, 2025 • 9:00am EDT

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings

Sign Up